AstraZeneca Pharma India gets DCGI nod for benralizumab injection, Fasenra
It is indicated as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult patients
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.